表紙
市場調査レポート

世界の中心静脈カテーテル市場:医療機器のパイプライン評価

Central Venous Catheters - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 229188
出版日 ページ情報 英文 55 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
世界の中心静脈カテーテル市場:医療機器のパイプライン評価 Central Venous Catheters - Medical Devices Pipeline Assessment, 2016
出版日: 2016年06月01日 ページ情報: 英文 55 Pages
概要

当レポートでは、世界の中心静脈カテーテル市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 中心静脈カテーテル市場の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 中心静脈カテーテル:治験中のパイプライン製品 (企業別)

  • 中心静脈カテーテルの企業:治験段階別のパイプライン製品
  • 中心静脈カテーテル:治験段階別のパイプライン製品

第5章 中心静脈カテーテル:企業・製品の概要

  • Ash Access Technology, Inc.
    • パイプライン製品および進行中の治験の概要
  • Bluegrass Vascular Technologies, Inc.
  • Charite - Universitatsmedizin Berlin
  • Globe Medical Tech, Inc.
  • i360medical Limited
  • Infusense Corp
  • Marvao Medical Devices Limited
  • ニプロ
  • Pavmed Inc
  • S3V Vascular Technologies
  • Sharklet Technologies, Inc.
  • Teleflex Incorporated
  • The Johns Hopkins University
  • The University of Utah
  • Vascular Access Technologies, Inc.
  • Vindica Therapeutics, Inc

第6章 中心静脈カテーテル市場:昨今の動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0197EPD

GlobalData's Medical Devices sector report, "Central Venous Catheters - Medical Devices Pipeline Assessment, 2016" provides an overview of Central Venous Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Venous Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Central Venous Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Venous Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Central Venous Catheters Overview

3. Products under Development

  • 3.1. Central Venous Catheters - Pipeline Products by Stage of Development
  • 3.2. Central Venous Catheters - Pipeline Products by Segment
  • 3.3. Central Venous Catheters - Pipeline Products by Territory
  • 3.4. Central Venous Catheters - Pipeline Products by Regulatory Path
  • 3.5. Central Venous Catheters - Pipeline Products by Estimated Approval Date
  • 3.6. Central Venous Catheters - Ongoing Clinical Trials

4. Central Venous Catheters - Pipeline Products under Development by Companies

  • 4.1. Central Venous Catheters Companies - Pipeline Products by Stage of Development
  • 4.2. Central Venous Catheters - Pipeline Products by Stage of Development

5. Central Venous Catheters Companies and Product Overview

  • 5.1. Ash Access Technology, Inc. Company Overview
    • 5.1.1. Ash Access Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. BioCardia, Inc. Company Overview
    • 5.2.1. BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Bluegrass Vascular Technologies, Inc. Company Overview
    • 5.3.1. Bluegrass Vascular Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Charite - Universitatsmedizin Berlin Company Overview
    • 5.4.1. Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Globe Medical Tech, Inc. Company Overview
    • 5.5.1. Globe Medical Tech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. i360medical Limited Company Overview
    • 5.6.1. i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Infusense Corp Company Overview
    • 5.7.1. Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. John Hopkins University Company Overview
    • 5.8.1. John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Marvao Medical Devices Limited Company Overview
    • 5.9.1. Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Nipro Corporation Company Overview
    • 5.10.1. Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Pavmed Inc Company Overview
    • 5.11.1. Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. S3V Vascular Technologies Company Overview
    • 5.12.1. S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Sharklet Technologies, Inc. Company Overview
    • 5.13.1. Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Teleflex Incorporated Company Overview
    • 5.14.1. Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. The University of Utah Company Overview
    • 5.15.1. The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Vascular Access Technologies, Inc. Company Overview
    • 5.16.1. Vascular Access Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Vindica Therapeutics, Inc Company Overview
    • 5.17.1. Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview

6. Central Venous Catheters- Recent Developments

  • 6.1. May 17, 2016: Retractable Technologies Reports Results for the First Quarter of 2016
  • 6.2. May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results
  • 6.3. May 13, 2016: B. Braun Focused on Helping Educate Nurses About USP and Improving Vascular Access at INS 2016
  • 6.4. May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026
  • 6.5. May 10, 2016: ICU Medical Announces First Quarter 2016 Results
  • 6.6. Apr 28, 2016: Teleflex Reports First Quarter 2016 Results
  • 6.7. Mar 29, 2016: Bluegrass Vascular Technologies Announces First Clinical Use of the Surfacer Inside-Out Access Catheter System in Europe
  • 6.8. Mar 29, 2016: Bio2 Medical Raises Additional USD1 Million in Series D Financing
  • 6.9. Feb 25, 2016: Teleflex Reports Fourth Quarter and Full Year 2015 Results; Provides 2016 Guidance
  • 6.10. Feb 03, 2016: ICU Medical Announces Fourth Quarter and Fiscal Year 2015 Results
  • 6.11. Jan 19, 2016: Leading Medical Device Companies Select Brainshark to Drive Sales Productivity
  • 6.12. Nov 30, 2015: Teleflex to focus on showcasing its Intraosseous and Central Vascular Access portfolio featuring chlorhexidine based technologies at GAVeCeLT 2015. - December 1-3, in Milan, Italy
  • 6.13. Nov 05, 2015: ICU Medical Announces Third Quarter 2015 Results
  • 6.14. Oct 29, 2015: Teleflex Reports Third Quarter 2015 Results
  • 6.15. Aug 17, 2015: Teleflex Signs New Agreement with Amerinet for Surgical Instruments
  • 6.16. Aug 10, 2015: ICU Medical Announces Second Quarter 2015 Results
  • 6.17. Jul 30, 2015: Teleflex Reports Second Quarter 2015 Results
  • 6.18. Jul 29, 2015: Teleflex Reports Study Results of ARROWg+ard Technology Effectiveness in Reducing Catheter Infections and Costs in Low Risk Population

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Central Venous Catheters - Pipeline Products by Stage of Development
  • Table 2: Central Venous Catheters - Pipeline Products by Segment
  • Table 3: Central Venous Catheters - Pipeline Products by Territory
  • Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path
  • Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date
  • Table 6: Central Venous Catheters - Ongoing Clinical Trials
  • Table 7: Central Venous Catheters Companies - Pipeline Products by Stage of Development
  • Table 8: Central Venous Catheters - Pipeline Products by Stage of Development
  • Table 9: Ash Access Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: BaxCath Impregnation System - Product Status
  • Table 11: BaxCath Impregnation System - Product Description
  • Table 12: BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Helix 953L Catheter - Product Status
  • Table 14: Helix 953L Catheter - Product Description
  • Table 15: Bluegrass Vascular Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Surfacer Inside-Out Access Catheter System - Product Status
  • Table 17: Surfacer Inside-Out Access Catheter System - Product Description
  • Table 18: Bluegrass Vascular Technologies, Inc. - Ongoing Clinical Trials Overview
  • Table 19: Surfacer Inside-Out Access Catheter System - Clinical Study of the Surfacer Inside-Out Access Catheter System
  • Table 20: Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Central Venous Permanent Catheter - Product Status
  • Table 22: Central Venous Permanent Catheter - Product Description
  • Table 23: Globe Medical Tech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Safety IV Catheter - Product Status
  • Table 25: Safety IV Catheter - Product Description
  • Table 26: i360medical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Suture-Less Insertion And Stabilization Device - IV Catheter Lines - Product Status
  • Table 28: Suture-Less Insertion And Stabilization Device - IV Catheter Lines - Product Description
  • Table 29: Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Infusense System - Product Status
  • Table 31: Infusense System - Product Description
  • Table 32: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: IV Catheter Placement Device - Product Status
  • Table 34: IV Catheter Placement Device - Product Description
  • Table 35: Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: NexSite 8Fr Single Lumen Central Venous Catheter - Product Status
  • Table 37: NexSite 8Fr Single Lumen Central Venous Catheter - Product Description
  • Table 38: Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Biocompatible Intravenous Catheter - Product Status
  • Table 40: Biocompatible Intravenous Catheter - Product Description
  • Table 41: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: NextCath - Product Status
  • Table 43: NextCath - Product Description
  • Table 44: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: 3V AGILE - Product Status
  • Table 46: 3V AGILE - Product Description
  • Table 47: Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Sharklet Central Venous Catheter - Product Status
  • Table 49: Sharklet Central Venous Catheter - Product Description
  • Table 50: Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: ARROW JACC Nurse Insertion CVC System - Product Status
  • Table 52: ARROW JACC Nurse Insertion CVC System - Product Description
  • Table 53: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: WIN NIC Central Venous Catheter Introducer Kit - Product Status
  • Table 55: WIN NIC Central Venous Catheter Introducer Kit - Product Description
  • Table 56: Vascular Access Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: SAFECVAD - Product Status
  • Table 58: SAFECVAD - Product Description
  • Table 59: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Status
  • Table 61: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Description
  • Table 62: Glossary

List of Figures

  • Figure 1: Central Venous Catheters - Pipeline Products by Stage of Development
  • Figure 2: Central Venous Catheters - Pipeline Products by Segment
  • Figure 3: Central Venous Catheters - Pipeline Products by Territory
  • Figure 4: Central Venous Catheters - Pipeline Products by Regulatory Path
  • Figure 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date
  • Figure 6: Central Venous Catheters - Ongoing Clinical Trials
Back to Top